SCHMIDT; Ann Marie

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHMIDT; Ann Marie.The latest application filed is for "indole compounds as modulators of rage activity and uses thereof".

Company Profile

10.37.62

SCHMIDT; Ann Marie - Franklin Lakes NJ
Schmidt; Ann Marie - New York NY
SCHMIDT; Ann Marie - US
SCHMIDT, ANN MARIE - FRANKLIN LAKE NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indole Compounds As Modulators Of Rage Activity And Uses Thereof App 20220296604 - SCHMIDT; Ann Marie ; et al.	2022-09-22
Quinoline compounds as modulators of RAGE activity and uses thereof Grant 11,192,859 - Schmidt , et al. December 7, 2	2021-12-07
Aldose Reductase Inhibitors And Uses Thereof App 20200289512 - WASMUTH; Andrew ; et al.	2020-09-17
Aldose Reductase Inhibitors And Uses Thereof App 20200268755 - WASMUTH; Andrew ; et al.	2020-08-27
Amino, amido and heterocyclic compounds as modulators of RAGE activity and uses thereof Grant 10,729,695 - Schmidt , et al.	2020-08-04
Aldose reductase inhibitors and uses thereof Grant 10,639,306 - Wasmuth , et al.	2020-05-05
Amino, Amido And Heterocyclic Compounds As Modulators Of Rage Activity And Uses Thereof App 20190374548 - Schmidt; Ann Marie ; et al.	2019-12-12
Aldose Reductase Inhibitors And Uses Thereof App 20190201400 - WASMUTH; Andrew ; et al.	2019-07-04
Quinoline Compounds As Modulators Of Rage Activity And Uses Thereof App 20190194136 - SCHMIDT; Ann Marie ; et al.	2019-06-27
Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof Grant 10,265,320 - Schmidt , et al.	2019-04-23
Aldose Reductase Inhibitors And Uses Thereof App 20180271865 - WASMUTH; Andrew ; et al.	2018-09-27
Aldose reductase inhibitors and uses thereof Grant 10,052,324 - Wasmuth , et al. August 21, 2	2018-08-21
Aldose Reductase Inhibitors And Uses Thereof App 20170319584 - WASMUTH; Andrew ; et al.	2017-11-09
Patient Condition Identification And Treatment App 20170308981 - Razavian; Narges Sharif ; et al.	2017-10-26
Aldose Reductase Inhibitors And Uses Thereof App 20170216291 - WASMUTH; Andrew ; et al.	2017-08-03
Aldose Reductase Inhibitors And Uses Thereof App 20170216292 - WASMUTH; Andrew ; et al.	2017-08-03
Aldose reductase inhibitors and uses thereof Grant 9,650,383 - Wasmuth , et al. May 16, 2	2017-05-16
Amino, Amido And Heterocyclic Compounds As Modulators Of Rage Activity And Uses Thereof App 20160263125 - Schmidt; Ann Marie ; et al.	2016-09-15
Amino, Amido and heterocyclic compounds as modulators of RAGE activity and uses thereof Grant 9,364,472 - Schmidt , et al. June 14, 2	2016-06-14
Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof Grant 9,353,078 - Schmidt , et al. May 31, 2	2016-05-31
Rage As A C1q Receptor, Methods And Applications App 20160139120 - BARILE; Gaetano R. ; et al.	2016-05-19
Amino, Amido And Heterocyclic Compounds As Modulators Of Rage Activity And Uses Thereof App 20160101096 - Schmidt; Ann Marie ; et al.	2016-04-14
Amino, Amido And Heterocyclic Compounds As Modulators Of Rage Activity And Uses Thereof App 20150094307 - Schmidt; Ann Marie ; et al.	2015-04-02
Aldose Reductase Inhibitors And Uses Thereof App 20150072989 - WASMUTH; Andrew ; et al.	2015-03-12
Aldose Reductase Inhibitors And Uses Thereof App 20130225592 - WASMUTH; Andrew ; et al.	2013-08-29
Rage Regulates Rock Activity In Cardiovascular Disease App 20130064835 - Schmidt; Ann Marie	2013-03-14
Assays And Methods Pertaining To Pre-amyloid Intermediates App 20130022620 - Schmidt; Ann Marie ; et al.	2013-01-24
Transgenic Mice Over-expressing Receptor For Advanced Glycation Endproduct (rage) In Brain And Uses Thereof App 20120291145 - Stern; David M. ; et al.	2012-11-15
Rage G82s-related Methods And Compositions For Treating Inflammatory Disorders App 20120128658 - Schmidt; Ann Marie ; et al.	2012-05-24
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury Grant 8,133,866 - Stern , et al. March 13, 2	2012-03-13
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof Grant 8,124,829 - Stern , et al. February 28, 2	2012-02-28
Antibody To Rage And Uses For In Vivo Imaging Or For Targeting Therapy App 20110311448 - Schmidt; Ann Marie ; et al.	2011-12-22
RAGE G82S-related methods and compositions for treating inflammatory disorders Grant 8,067,371 - Schmidt , et al. November 29, 2	2011-11-29
Transgenic Mice Over-Expressing Receptor For Advanced Glycation Endproduct (RAGE) In Brain And Uses Thereof App 20110126298 - Stern; David M. ; et al.	2011-05-26
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof Grant 7,919,670 - Stern , et al. April 5, 2	2011-04-05
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury App 20100292134 - Stern; David M. ; et al.	2010-11-18
Method for treating symptoms of diabetes App 20100255081 - Stern; David M. ; et al.	2010-10-07
Uses Of Rage Antagonists For Treating Obesity And Related Diseases App 20100254983 - Schmidt; Ann Marie ; et al.	2010-10-07
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury Grant 7,732,400 - Stern , et al. June 8, 2	2010-06-08
Method for treating symptoms of diabetes Grant 7,700,085 - Stern , et al. April 20, 2	2010-04-20
Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof App 20090228997 - Schmidt; Ann Marie ; et al.	2009-09-10
Rage/Diaphanous Interaction and Related Compositions and Methods App 20090220484 - Schmidt; Ann Marie ; et al.	2009-09-03
Rage Fusion Proteins and Methods of Use App 20090060925 - Mjalli; Adnan M.M. ; et al.	2009-03-05
Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia Grant 7,494,972 - Stern , et al. February 24, 2	2009-02-24
Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof App 20090028882 - Stern; David M. ; et al.	2009-01-29
Methods for treating inflammation App 20080214453 - Stern; David M. ; et al.	2008-09-04
Rage-related methods for treating and preventing diabetic retinopathy App 20080207499 - Barile; Gaetano ; et al.	2008-08-28
Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury App 20080171701 - Stern; David M. ; et al.	2008-07-17
Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof App 20080019986 - Stern; David ; et al.	2008-01-24
Rage-related methods for treating inflammation Grant 7,258,857 - Stern , et al. August 21, 2	2007-08-21
Methods for treating and preventing diabetic retinopathy App 20070098709 - Barile; Gaetano ; et al.	2007-05-03
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts App 20070099829 - Stern; David ; et al.	2007-05-03
Rage-related methods and copositions for treating glomerular injury App 20070014791 - Schmidt; Ann Marie ; et al.	2007-01-18
Method for inhibiting tumor invasion or spreading in a subject Grant 7,125,675 - Schmidt , et al. October 24, 2	2006-10-24
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts Grant 7,101,838 - Stern , et al. September 5, 2	2006-09-05
Extracellular rage binding protein (EN-RAGE) and uses thereof Grant 7,081,241 - Schmidt , et al. July 25, 2	2006-07-25
Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof Grant 7,026,444 - Schmidt , et al. April 11, 2	2006-04-11
Methods for treating an ischemic disorder and improving stroke outcome App 20050250688 - Pinsky, David J. ; et al.	2005-11-10
RAGE-related compositions App 20050170382 - Stern, David M. ; et al.	2005-08-04
RAGE G82S-related methods and compositions for treating inflammatory disorders App 20050129682 - Schmidt, Ann Marie ; et al.	2005-06-16
Method to increase cerebral blood flow in amyloid angiopathy Grant 6,825,164 - Stern , et al. November 30, 2	2004-11-30
Method for treating symptoms of diabetes App 20040228855 - Stern, David M. ; et al.	2004-11-18
Method for treating symptoms of diabetes Grant 6,790,443 - Stern , et al. September 14, 2	2004-09-14
Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE App 20040142391 - Schmidt, Ann Marie ; et al.	2004-07-22
Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof App 20040121372 - Schmidt, Ann Marie ; et al.	2004-06-24
Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage Grant 6,753,150 - Schmidt , et al. June 22, 2	2004-06-22
Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof App 20040043412 - Schmidt, Ann Marie ; et al.	2004-03-04
Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation App 20040038898 - Rose, Eric ; et al.	2004-02-26
Method to increase cerebral blood flow in amyloid angiopathy Grant 6,677,299 - Stern , et al. January 13, 2	2004-01-13
Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof Grant 6,670,136 - Schmidt , et al. December 30, 2	2003-12-30
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof Grant 6,563,015 - Stern , et al. May 13, 2	2003-05-13
Method For Determing Whether A Compound Is Capable Of Inhibiting The Interaction Of A Peptide With Rage App 20030087302 - SCHMIDT, ANN MARIE ; et al.	2003-05-08
Ligand binding site of rage and uses thereof Grant 6,555,651 - Stern , et al. April 29, 2	2003-04-29
Nucleic acid encoding bovine extracellular rage binding protein (en-rage) Grant 6,555,340 - Schmidt , et al. April 29, 2	2003-04-29
Method For Treating Symptoms Of Diabetes App 20030059423 - STERN, DAVID M. ; et al.	2003-03-27
Method for inhibiting tumor invasion or spreading in a subject App 20020177550 - Schmidt, Ann Marie ; et al.	2002-11-28
Method for inhibiting tumor invasion or spreading in a subject Grant 6,465,422 - Schmidt , et al. October 15, 2	2002-10-15
Methods for treating inflammation App 20020122799 - Stern, David M. ; et al.	2002-09-05
Method to increase cerebral blood flow in amyloid angiopathy App 20020116725 - Stern, David M. ; et al.	2002-08-22
Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof App 20020106726 - Schmidt, Ann Marie ; et al.	2002-08-08
Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation Grant 6,391,300 - Rose , et al. May 21, 2	2002-05-21
Ligand Binding Site Of Rage And Uses Thereof App 20010053357 - STERN, DAVID ; et al.	2001-12-20
Methods for treating an ischemic disorder and improving stroke outcome Grant 6,316,403 - Pinsky , et al. November 13, 2	2001-11-13
Methods for treating an ischemic disorder and improving stroke outcome Grant 6,315,995 - Pinsky , et al. November 13, 2	2001-11-13
Method To Prevent Accelerated Atherosclerosis Using (srage) Soluble Receptor For Advanced Glycation Endproducts App 20010039256 - STERN, DAVID ; et al.	2001-11-08
Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation Grant 5,839,443 - Rose , et al. November 24, 1	1998-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.